"Receptors, Opioid, delta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.
MeSH Number(s)
D12.776.543.750.100.620.200
D12.776.543.750.720.600.610.200
D12.776.543.750.750.555.610.200
Concept/Terms
Receptors, Opioid, delta- Receptors, Opioid, delta
- Opioid Receptors, delta
- delta Opioid Receptors
- Receptors, delta Opioid
- Receptors, delta
- delta Receptor
- Receptor, delta
- delta Receptors
- delta Opioid Receptor
- Opioid Receptor, delta
- Receptor, delta Opioid
Below are MeSH descriptors whose meaning is more general than "Receptors, Opioid, delta".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Opioid [D12.776.543.750.100.620]
- Receptors, Opioid, delta [D12.776.543.750.100.620.200]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Opioid [D12.776.543.750.720.600.610]
- Receptors, Opioid, delta [D12.776.543.750.720.600.610.200]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Opioid [D12.776.543.750.750.555.610]
- Receptors, Opioid, delta [D12.776.543.750.750.555.610.200]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Opioid, delta".
This graph shows the total number of publications written about "Receptors, Opioid, delta" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Opioid, delta" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 1 | 1 |
| 1992 | 1 | 0 | 1 |
| 1993 | 2 | 0 | 2 |
| 1995 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 2 | 4 |
| 2010 | 1 | 1 | 2 |
| 2011 | 4 | 0 | 4 |
| 2012 | 2 | 1 | 3 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 3 | 1 | 4 |
| 2020 | 1 | 0 | 1 |
Below are the most recent publications written about "Receptors, Opioid, delta" by people in Profiles.
-
The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules. 2020 Jun 06; 25(11).
-
Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides. Eur Neuropsychopharmacol. 2019 03; 29(3):450-456.
-
Involvement of opioid system in behavioral despair induced by social isolation stress in mice. Biomed Pharmacother. 2019 Jan; 109:938-944.
-
In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder. J Pharmacol Exp Ther. 2018 11; 367(2):267-281.
-
Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits. Neuron. 2018 04 04; 98(1):90-108.e5.
-
A Caged Enkephalin Optimized for Simultaneously Probing Mu and Delta Opioid Receptors. ACS Chem Neurosci. 2018 04 18; 9(4):684-690.
-
Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human d-opioid receptor turnover at the plasma membrane. Cell Signal. 2018 Jan; 42:184-193.
-
Input-Timing-Dependent Plasticity in the Hippocampal CA2 Region and Its Potential Role in Social Memory. Neuron. 2017 Aug 30; 95(5):1089-1102.e5.
-
A novel regulatory role of RGS4 in STAT5B activation, neurite outgrowth and neuronal differentiation. Neuropharmacology. 2017 05 01; 117:408-421.
-
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology (Berl). 2016 Mar; 233(6):1119-30.